Quantbot Technologies LP Atreca, Inc. Transaction History

Quantbot Technologies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $2,254 - $7,280	-1,400 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$4.91 - $9.07 $5,401 - $9,977	1,100 Added 366.67%	1,400 $8,000
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $3,801 - $6,957	300 New	300 $4,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.